Dow Jones

51 564,70

0,14%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

Accueil
Investir
Actions
Etats-Unis
USOTC
Covalon Technologies Ltd (QX) (CVALF)
Covalon Technologies Ltd (QX) (CVALF) Actualités

Covalon Technologies Ltd (QX) (CVALF)

1,54

0,00

(0,00%)

Fermé 22 Juin 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones...

Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the...

Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving...

Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving...

Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its...

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its...

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 Covalon Technologies Ltd. (the "Company" or...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

USOTC

CVALF

Covalon Technologies (QX)

1.125% until 23jun2030 1...

TG

RYSC

Royal Bank of Scotland

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Covalon Technologies Ltd (QX) (CVALF)

Votre Hub pour des idées et discussions en direct en temps réel